Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2026-01-02 @ 7:44 AM
Study NCT ID:
NCT00422435
Status:
COMPLETED
Last Update Posted:
2008-10-24
First Post:
2007-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation
Sponsor:
Conor Medsystems
Organization:
Study Overview
Official Title:
The PreCiSE Trial: CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation
Status:
COMPLETED
Status Verified Date:
2008-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to evaluate the performance and safety of a new catheter system.
Detailed Description:
This study is designed to evaluate acute Device Success, defined as attainment of \<50% residual stenosis of the target lesion.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: